Pages that link to "Q54513582"
Jump to navigation
Jump to search
The following pages link to In vitro mefloquine resistant Plasmodium falciparum from the Philippines (Q54513582):
Displaying 13 items.
- Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy (Q34058524) (← links)
- Antimalarial agents: specific treatment regimens (Q35311814) (← links)
- Halofantrine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic potential (Q35312006) (← links)
- RII and RIII type resistance of Plasmodium falciparum to combination of mefloquine and sulfadoxine/pyrimethamine in Indonesia (Q36413985) (← links)
- Falciparum malaria treated with a fixed combination of mefloquine, sulfadoxine and pyrimethamine: a field study in adults in Burma (Q36875917) (← links)
- Malaria in travelers in rhode island: A review of 26 cases (Q37202714) (← links)
- Genetic diversity in Plasmodium falciparum (Q37911988) (← links)
- In-vitro tests on Philippine isolates of Plasmodium falciparum against four standard antimalarials and four qinghaosu derivatives. (Q38927119) (← links)
- The problem of drug resistance in malaria (Q39351747) (← links)
- Malaria prophylaxis in travellers: the current position (Q40096101) (← links)
- Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose (Q40801796) (← links)
- Randomised comparative study of mefloquine, qinghaosu, and pyrimethamine-sulfadoxine in patients with falciparum malaria (Q41918058) (← links)
- Misuse of mefloquine for malaria prophylaxis in Zimbabwe (Q46820285) (← links)